valsartan is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Valsartan.
| Product ID | 13668-070_4138763c-6d18-492f-a043-f8a41eac6901 |
| NDC | 13668-070 |
| Product Type | Human Prescription Drug |
| Proprietary Name | valsartan |
| Generic Name | Valsartan |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2015-01-05 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA202728 |
| Labeler Name | Torrent Pharmaceuticals Limited |
| Substance Name | VALSARTAN |
| Active Ingredient Strength | 320 mg/1 |
| Pharm Classes | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-01-05 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA202728 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2015-01-05 |
| Marketing End Date | 2018-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202728 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-05 |
| Marketing End Date | 2018-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202728 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-05 |
| Marketing End Date | 2018-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202728 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-05 |
| Marketing End Date | 2018-12-31 |
| Marketing Category | ANDA |
| Application Number | ANDA202728 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-01-05 |
| Marketing End Date | 2018-12-31 |
| Ingredient | Strength |
|---|---|
| VALSARTAN | 320 mg/1 |
| SPL SET ID: | 6365803f-61f8-476d-b760-c70daa17d551 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |